Article
The MUC5B Promoter Polymorphism is Not Associated With Non-ILD Chronic Respiratory Diseases or Post-transplant Outcome.
Transplant international : official journal of the European Society for Organ Transplantation - 1 Jan 2022
Goos Tinne, Verleden Stijn E, De Sadeleer Laurens J, Van Herck Anke, Sacreas Annelore, Vanstapel Arno, Kaes Janne, Geudens Vincent, Aelbrecht Celine, Ruttens David, Lambrechts Diether, Vermeer Sascha, Ceulemans Laurens J, Van Raemdonck Dirk E, Godinas Laurent, Yserbyt Jonas, Vanaudenaerde Bart M, Verleden Geert M, Vos Robin, Wuyts Wim A
Abstract excerpt
The MUC5B promoter polymorphism (rs35705950) has been associated with interstitial lung disease (ILD) and with prolonged pre-transplant survival in idiopathic pulmonary fibrosis (IPF), but no information is available regarding its prevalence in other respiratory diseases and its influence on post-transplant outcome. We included the Leuven lung transplantation cohort between 1991 and 2015 (n = 801). We assessed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.